BiotechTube

GODEX + Placebo

Phase 3Recruiting
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Non-Alcoholic Fatty Liver Disease

Conditions

Non-Alcoholic Fatty Liver Disease

Trial Timeline

Sep 25, 2023 → Feb 26, 2027

NCT ID
NCT06152991

About GODEX + Placebo

GODEX + Placebo is a phase 3 stage product being developed by Celltrion for Non-Alcoholic Fatty Liver Disease. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06152991. Target conditions include Non-Alcoholic Fatty Liver Disease.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT06152991Phase 3Recruiting

Competing Products

20 competing products in Non-Alcoholic Fatty Liver Disease

See all competitors
ProductCompanyStageHype Score
IVA337 + IVA337 + PlaceboInventivaPhase 2
47
ASP9831 + PlaceboAstellas PharmaPhase 2
52
AZD9550 + AZD9550 + PlaceboAstraZenecaPhase 1
33
AZD2693AstraZenecaPhase 1
33
placebo + Omega-3 carboxylic acids + Dapagliflozin + PlaceboAstraZenecaPhase 2
52
AZD4831AstraZenecaPhase 2
52
AZ compoundAstraZenecaPhase 2
52
cotadutide solution for injectionAstraZenecaPhase 1
33
Cotadutide + Cotadutide-placebo + Moxifloxacin + Moxifloxacin-placeboAstraZenecaPhase 1
33
AZD4076 + PlaceboAstraZenecaPhase 1
33
Placebo + Omega-3 carboxylic acid + Fenofibrate 200mg + PlaceboAstraZenecaPhase 2
52
Cotadutide + PlaceboAstraZenecaPhase 2
52
AZD7503 InterventionAstraZenecaPhase 1
33
Efinopegdutide + Semaglutide + PlaceboMerckPhase 2
52
MK-4074 200 mg + Placebo for MK-4074 + Pioglitazone hydrochloride 30 mg + Placebo for pioglitazone hydrochlorideMerckPhase 1
33
EfinopegdutideMerckPhase 1
33
LIK066 + PlaceboNovartisPhase 2
52
Tropifexor (LJN452) + Cenicriviroc (CVC)NovartisPhase 2
52
LYS006 + TropifexorNovartisPhase 2
52
LMB763 + PlaceboNovartisPhase 2
52

Other Products from Celltrion

Azathioprine + PlaceboApproved
85
Infliximab CT-P13 + Immunosuppressors (Thiopurines or Methotrexate)Approved
85
Infliximab + Infliximab + InfliximabApproved
85
Pioglitazone + Alogliptin + Alogliptin + Metformin + DapagliflozinApproved
85
Pioglitazone 15 MG [Actos] + Empagliflozin 10 MG [Jardiance] + Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Actos]Approved
85